The world is on the verge of being able to protect humans against Ebola according to the World Health Organization, after a trial in Guinea found that a vaccine was 100 percent effective.
Initial results from the trial, which tested Merck (MRK.N) and NewLink Genetics’ (NLNK.O) VSV-ZEBOV vaccine on some 4,000 people who had been in close contact with a confirmed Ebola case, showed complete protection after 10 days.
The results were dubbed “remarkable” and “game changing” by global health specialists.
The vaccine could now be used to help end the worst recorded outbreak of Ebola, which has claimed more than 11,000 lives in West Africa since it began in December 2013.
WHO Director-General Margaret Chan said the results, published online in the medical journal The Lancet, would “change the management of the current Ebola outbreak and future outbreaks”.